Talia Puzantian, PharmD, BCPP

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024)

PDF/eBook Access with 12 CME Post-Test For A Regular Bound Copy

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to the information provided in this book.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) and download links PDF/eBook access.

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to the information provided in this book.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) and download links PDF/eBook access.

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) and download links PDF/eBook access.

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) and download links PDF/eBook access.

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) and download links PDF/eBook access.

The Medication Fact Book for Psychiatric Practice, Fifth Edition (2020)

PDF Access and CME Post-Test

February 29, 2020

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed that they has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of The Medication Fact Book for Psychiatric Practice, Fifth Edition (2020) and completing the 12 CME Post-Test.

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

First Non-Drug Treatment Approved by FDA for Treating Children With ADHD

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the article we discuss the effectiveness and safety of the first non-drug treatment for ADHD in kids. The FDA has recently granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications.

New Approvals for TMS

November 1, 2018

Talia Puzantian, PharmD, BCPP and Chris Aiken, MD

Talia Puzantian, PharmD, BCPP Chris Aiken, MD Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We know that transcranial magnetic stimulation (TMS) works for treatment-resistant depression (TRD), but one disadvantage is the length of the treatment sessions.

Jornay PM Nighttime Stimulant for Next-Morning Effect

November 1, 2018

Talia Puzantian, PharmD, BCPP

Talia Puzantian, PharmD, BCPP Dr. Puzantian has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prescribing bedtime stimulants sounds like a recipe for a bad night’s sleep. But the FDA recently approved Jornay PM, which is an extended release (ER) formulation of methylphenidate that is, in fact, dosed at night.